ChemicalBook >> CAS DataBase List >>BI 2536

BI 2536

CAS No.
755038-02-9
Chemical Name:
BI 2536
Synonyms
BI 2536;CS-1984;BI-2536(R-);(R)-BI-2536;BI 2536, >=98%;BI2536/BI-2536;BI 2536 USP/EP/BP;BI 2536;BI-2536; BI2536;Boehringer PLK-1 inhibitor;BI-2536, BoehringerPLK-1 inhibitor
CBNumber:
CB31562104
Molecular Formula:
C28H39N7O3
Molecular Weight:
521.65
MDL Number:
MFCD10565924
MOL File:
755038-02-9.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:19

BI 2536 Properties

Density 1.28
storage temp. Keep in dark place,Sealed in dry,Store in freezer, under -20°C
solubility Soluble in DMSO (up to 20 mg/ml) or in Ethanol (up to 25 mg/ml)
form Yellow powder.
pka 14.09±0.20(Predicted)
color Off-white
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
NCI Dictionary of Cancer Terms BI 2536
FDA UNII 4LJG22T9C6
NCI Drug Dictionary BI 2536

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P280-P305+P351+P338

BI 2536 price More Price(42)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 17385 BI 2536 ≥95% 755038-02-9 1mg $37 2024-03-01 Buy
Cayman Chemical 17385 BI 2536 ≥95% 755038-02-9 5mg $116 2024-03-01 Buy
Cayman Chemical 17385 BI 2536 ≥95% 755038-02-9 10mg $178 2024-03-01 Buy
Cayman Chemical 17385 BI 2536 ≥95% 755038-02-9 50mg $758 2024-03-01 Buy
TRC B373470 BI2536 755038-02-9 5mg $105 2021-12-16 Buy
Product number Packaging Price Buy
17385 1mg $37 Buy
17385 5mg $116 Buy
17385 10mg $178 Buy
17385 50mg $758 Buy
B373470 5mg $105 Buy

BI 2536 Chemical Properties,Uses,Production

Description

BI 2536 (755038-02-9) was originally reported as a potent (IC50’s Plk1 = 0.83nM, Plk2 = 3.5nM and Plk3 = 9.0nM)1?and selective2?Polo-like kinase inhibitor?that caused mitotic arrest and apoptosis induction in various human cancer cell lines.1?It was later found to be a potent inhibitor (IC50?= 100nM) of BET family member BRD4 and able to potently suppress c-Myc expression in MM.1S multiple myeloma cells.3?BI 2536 destabilizes N-Myc by inhibiting the deactivation of the ubiquitin E3 ligase Fbw7 by Plk1.4

Uses

BI 2536 is a PLK1 inhibitor, inducing apoptosis together with micro-tubule-destabilizing drugs in preclinical rhabdomyosarcoma models. Anti-cancer and potent PLK1 inhibitor.

target

Plk1

References

1) Steegmaier?et al.?(2007),?BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo; Curr. Biol.,?17?316 2) Davis?et al.?(2011),?Comprehensive analysis of kinase inhibitor selectivity; Nat. Biotechnol.,?29?1046 3) Ciceri?et al.?(2014),?Dual kinase-bromodomain inhibitors for rationally designed polypharmacology; Nat. Chem. Biol.,?10?305 4) Xiao?et al.?(2016),?Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival; Mol. Cell,?64?493

BI 2536 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 160)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 47465 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626 eric@witopchemical.com China 23556 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29322 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58

BI 2536 Spectrum

BI-2536, BoehringerPLK-1 inhibitor 4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide BI 2536 Benzamide, 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)- Boehringer PLK-1 inhibitor BI-2536(R-) BI2536/BI-2536 (R)-4-((8-cyclopentyl-7-ethyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide 4-(8-cyclopentyl-7-ethyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylaMino)-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide BI 2536 4-[[(7R)-8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide BI 2536, >=98% 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide BI 2536;BI-2536; BI2536 (R)-BI-2536 (R)-4-((8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy- CS-1984 BI 2536 USP/EP/BP BI-2536 Plk1 inhibitor potent ATP-competitive 755038-02-9 755038-03-9 C28H39N7O3 Inhibitors API